Pesquisar
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030
DMIIRAdicionar à lista de desejos
0.081USD
+0.000+0.25%
Fechamento 07/02, 13:00（ET）Cotações atrasadas em 15 min
0.00Valor de mercado
--P/L TTM
Mais detalhes de Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 Empresa
Drugs Made In America Acquisition II Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to search for business combination targets in the pharmaceutical industry. The Company is neither engaged in any operations nor generated any revenues.
Informações de Drugs Made In America Acquisition II Rights Exp 16 Sep 2030
Código da empresaDMIIR
Nome da EmpresaDrugs Made In America Acquisition II Corp
Data de listagemSep 25, 2025
CEOStockwell (Lynn)
Número de funcionários- -
Tipo de títulosRight
Fim do ano fiscal- -
Endereço1 East Broward Boulevard
CidadeFT LAUDERDALE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal33301
Telefone19548703099
Site
Código da empresaDMIIR
Data de listagemSep 25, 2025
CEOStockwell (Lynn)
Executivos da empresa Drugs Made In America Acquisition II Rights Exp 16 Sep 2030
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director
Independent Director
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director
Independent Director
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director
Independent Director
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director
Independent Director
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Perguntas frequentes
Quem são os cinco principais acionistas de Drugs Made In America Acquisition II Rights Exp 16 Sep 2030?
Os cinco principais acionistas de Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 são: Ms. Lynn Stockwell